Mesoblast (MESO) Shares Issued (2017 - 2025)
Mesoblast recorded quarterly Shares Issued of -$3.9 million in Q4 2025, down 221.86% quarter-over-quarter from $3.2 million in Q4 2024, and down 221.86% year-over-year from $3.2 million in Q4 2024.
Mesoblast's Shares Issued history runs 8 years deep, the most recent figure standing at -$3.9 million for Q4 2025.
- In Q4 2025, Shares Issued fell 221.86% year-over-year to -$3.9 million; the TTM figure through Dec 2025 stood at -$3.9 million (down 221.86% YoY), while the FY2025 annual figure was $5.2 million, down 92.08% from the prior year.
- Shares Issued came in at -$3.9 million for Q4 2025 at Mesoblast, down from $3.2 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $110.0 million in Q1 2021 to a low of -$45.1 million in Q2 2023.
- A 5-year average of $7.0 million and a median of $62000.0 in 2021 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued slumped 95.67% in 2021 and plunged 1770.97% in 2022, its largest moves.
- Mesoblast's Shares Issued stood at $62000.0 in 2021, then slumped by 1770.97% to -$1.0 million in 2022, then slumped by 4249.9% to -$45.1 million in 2023, then soared by 107.07% to $3.2 million in 2024, then plunged by 221.86% to -$3.9 million in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered -$3.9 million, $3.2 million, and -$45.1 million for Q4 2025, Q4 2024, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.89 Mn |
| Dec 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Jun 30, 2023 | -45.07 Mn |
| Jun 30, 2023 | -45.07 Mn |
| Mar 31, 2023 | -1.04 Mn |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -1.04 Mn |
| Dec 31, 2022 | -1.04 Mn |
| Dec 31, 2021 | 62,000.00 |
| Dec 31, 2021 | 62,000.00 |
| Sep 30, 2021 | 147,000.00 |
| Sep 30, 2021 | 147,000.00 |
| Jun 30, 2021 | 684,000.00 |
| Jun 30, 2021 | 684,000.00 |
| Mar 31, 2021 | 110.00 Mn |
| Mar 31, 2021 | 110.00 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Sep 30, 2020 | 8.13 Mn |
| Sep 30, 2020 | 8.13 Mn |
| Sep 30, 2018 | 10.05 Mn |
| Sep 30, 2018 | 10.05 Mn |
| Mar 31, 2018 | 34,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Dec 31, 2017 | 83,000.00 |
| Dec 31, 2017 | 83,000.00 |
| Sep 30, 2017 | 40.45 Mn |
| Sep 30, 2017 | 40.45 Mn |
| Jun 30, 2017 | 148,000.00 |
| Jun 30, 2017 | 148,000.00 |